Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2023 Jul 18;4(7):101077.
doi: 10.1016/j.xcrm.2023.101077.

Answer to the Hamlet-like dilemma of lipid metabolites causing senile macular degeneration

Affiliations
Comment

Answer to the Hamlet-like dilemma of lipid metabolites causing senile macular degeneration

Valeria Lo Faro. Cell Rep Med. .

Abstract

In this issue of Cell Reports Medicine, Han et al.1 conducted a multi-ancestry genetic and metabolomic analysis to investigate the causal relationships between age-related macular degeneration and plasma and urine metabolites.

PubMed Disclaimer

Conflict of interest statement

Declaration of interests The author declares no competing interests.

Figures

Figure 1
Figure 1
Summary and prospective of the study Previous studies successfully identified metabolites associated with age-related macular degeneration (AMD), but their causality in a genome-wide approach have not been addressed. Omics technologies, such as genomics and metabolomics, contribute to providing a more holistic view of the pathological processes. The integrative multi-omics approach that combined multi-ancestry metabolomics data (collected from plasma and urine samples) with genomics data, followed by bidirectional Mendelian randomization analyses, provided further biological insights into the causative role of lipid metabolites (i.e., glycerophospholipids, which are also found in biological membranes and lipoproteins). If further validated as AMD biomarkers, lipid metabolites will improve the detection of the disease. Figure created with BioRender.com.

Comment on

References

    1. Han X., Jun L., Jinglun L., Chen Y., Yu B., Qibin Q., Boerwinkle E., Kaplan R., Thyagarajan B., Daviglus M., et al. Integrating genetics and metabolomics from multi-ethnic and multi-fluid data reveals putative mechanisms for age-related macular degeneration. Cell Rep Med. 2023;4 - PMC - PubMed
    1. Fleckenstein M., Keenan T.D.L., Guymer R.H., Chakravarthy U., Schmitz-Valckenberg S., Klaver C.C., Wong W.T., Chew E.Y. Age-related macular degeneration. Nat. Rev. Dis. Primers. 2021 May 6;7:31. - PubMed
    1. Hasin Y., Seldin M., Lusis A. Multi-omics approaches to disease. Genome Biol. 2017 May 5;18:83. - PMC - PubMed
    1. Fritsche L.G., Igl W., Bailey J.N.C., Grassmann F., Sengupta S., Bragg-Gresham J.L., Burdon K.P., Hebbring S.J., Wen C., Gorski M., et al. A large genome-wide association study of age-related macular degeneration highlights contributions of rare and common variants. Nat. Genet. 2016 Feb;48:134–143. - PMC - PubMed
    1. Laíns I., Kelly R.S., Miller J.B., Silva R., Vavvas D.G., Kim I.K., Murta J.N., Lasky-Su J., Miller J.W., Husain D. Human Plasma Metabolomics Study across All Stages of Age-Related Macular Degeneration Identifies Potential Lipid Biomarkers. Ophthalmology. 2018 Feb;125:245–254. - PMC - PubMed

Supplementary concepts